Secondary Logo

Journal Logo

June 2020 - Volume 27 - Issue 6

  • Isaac Schiff, MD
  • 1530-0374
  • 12 issues per year
  • Obstetrics & Gynecology 12/83
  • 2.942
In the paper by Donneyong et al titled "The Women's Health Initiative Estrogen-Alone Trial Had Differential Disease and Medical Expenditure Consequences Across Age Groups," the theme of the analysis was to quantify the age specific disease associated medical expenditures attributable to reduced estrogen therapy (ET) utilization after the Women's Health Initiative Hormone Therapy trials. The findings showed that the decline in ET utilization had differential disease and expenditure consequences by age group in the United States. 

Isaac Schiff, CM, MD

Video Gallery

Access to 2019 issues of Menopause will be available online on the journal website:—accessible via your computer and portable devices.

NAMS Members:
You may continue to access all issues of Menopause via the Member Section of the NAMS website:

Members who want to take advantage of the personalization features that the journal website offers can register today for their online access to Menopause.

Current Issue Highlights

The Women's Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groups

Donneyong, Macarius M.; Chang, Teng-Jen; Roth, Joshua A.; More

Menopause. 27(6):632-639, June 2020.

        -hosted by Dr Marla Shapiro 

Videos for Professionals
Videos for Consumers

NAMS Members are invited to subscribe
to the following exclusive e-newsletters

First to Know
Menopause e-Consult
Menopause Care Updates

Not a Member? Join Now